-
Protein biomarkers
Changes in protein expression and modification levels are biomarkers for a variety of diseases. Aperbio's protein electrophoresis and blotting imaging systems and Echo microscopy systems can help you in your research and development process.
-
Nucleic acid biomarkers
Copy number variation, gene mutation, and alterations in gene transcription at the genomic level are intricately linked to the onset and progression of diseases, including cancers, and serve as potential biomarkers for these conditions. Aperbio's Pangaea qPCR system, Naica digital PCR system, and Echo microscopy system are designed to deliver stable and reliable analytical capabilities.
-
Epigenetic biomarkers
Epigenetic biomarkers hold significant potential for advancing clinical applications due to their ability to bridge the gap between molecular markers and the influence of lifestyle and environmental factors on disease development. Additionally, these markers exhibit superior stability. Aperbio's Naica digital PCR system and Pangaea fast quantitative PCR system offer a comprehensive solution.
-
Total solution service
Regulatory agencies have increasingly stringent safety requirements for cell and gene therapy products. Aperbio's Pangu qPCR system and Naica digital PCR system can provide solutions for stem cell residues, detection of pathogenic microorganisms such as mycoplasma, and proof of cell origin.
